What lies beneath the surface? Ultrasound is revealing the earliest signs of psoriatic arthritis, and changing care in the ...
TREMFYA® (guselkumab) is now clinically proven to protect joints in active psoriatic arthritis, offering durable efficacy and ...
Discover how early biologic therapy compares with standard care in psoriatic arthritis. Learn more about treatment strategies ...
Johnson & Johnson (J&J) has announced new data showing that Tremfya (guselkumab) reduces symptoms of psoriatic arthritis (PsA ...
Everyday Health on MSN
What Psoriatic Arthritis Really Feels Like
Joint pain, fatigue, and flares that strike without warning can make life with psoriatic arthritis challenging. Here's a ...
In the video, Dr. Nicola J. Gullick, a Consultant Rheumatologist in Coventry and one of the investigators on the PRO-SPIRIT ...
13h
The Inner Circle acknowledges, Donald Massenburg, MD, Ph.D, FACP, FACR as a Pinnacle Lifetime Member
GREEN BAY, Wis., Nov. 28, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Donald Massenburg, MD, Ph.D, FACP, FACR is recognized as a Pinnacle Lifetime Member for his contributions to ...
Pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations, ...
In older adults with psoriasis or psoriatic arthritis, use of two biologic classes was associated with lowest rates of serious adverse events than time off those drugs.
A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.
SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...
In this video interview with Healio, Micaela F. Bayard, MD, discussed the use of GLP-1 receptor agonists in treating patients with rheumatoid arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback